Health Care

McAfee warned the launch of health-care exchanges will likely inspire phishing attacks aimed at stealing personal information.

The U.S. hospital operator has reportedly received buyout interest from Community Health Systems and others.

In a 5-3 vote, the Supreme Court ruled the Federal Trade Commission can challenge deals brand-name drug companies make with generic rivals that keep cheaper products off the market.

Food regulators are looking into the potential impact of Wrigley's new Alert Energy Caffeine Gum on children and adolescents. 

The shipping giant agreed to forfeit $40 million in payments received from doing business with illicit online pharmacies.

The U.S. Securities and Exchange Commission is investigating allegations that Andrew Liveris, chairman and chief executive officer of industrial giant Dow Chemical, misused company funds for personal benefit, according to people familiar with the matter.

Former Turing Pharmaceuticals Chief Executive Officer Martin Shkreli invoked his Fifth Amendment right against self-incrimination and declined to answer questions from U.S. lawmakers.

Former first lady Nancy Reagan was a ‘true champion’ of Alzheimer’s disease.

WebMD elevated David Schlanger to the permanent CEO position after the company veteran served a three-month stint as interim CEO.

On Wednesday, Apple executives spoke about how their new Apple Watch is going to change health care.

BlackBerry bought a minority stake in health IT firm NantHealth in a bid to improve data sharing and communication in the health-care industry.

Eli Lilly received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.

Two major companies in a prominent $1.4 billion Asia investment fund managed by banking giant Morgan Stanley failed to file their financial statements on time, freezing trading in their stocks.

Drugmaker Merck has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.

The Supreme Court has sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.

Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the company's patents protecting its top-selling antibiotic just hours after the deal was announced this week.

Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection.

The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial that targets the less-obvious sufferers of the sexual condition: women.

CEOs have the urge to merge as global M&A hits $4 trillion for just the second time in history topped off by Activision's $6 billion purchase of Candy Crush maker King.